“With compelling Phase 2b osteosarcoma data, the anticipated FDA approval of OST-HER2, and the potential to earn a saleable Priority Review Voucher, the Company is positioned to unlock the full ...

Texans are getting their first look at a bill lawmakers hope to pass this legislative session to create a school choice ...

This story has been updated since original publication. Tennessee lawmakers backing a private-school voucher plan got a ...

(RTTNews) - OS Therapies, Inc. (OSTX) Wednesday announced that it has entered into an asset purchase agreement to acquire the listeria monocytogenes-based immuno-oncology programs and related ...

The press release notes the potential for expedited access to treatments through the FDA's Rare Pediatric Disease Priority Review Voucher program, which can provide significant financial benefits.

School choice, vouchers and the future of Texas educationJaden Edison, The Texas Tribune, Graphics by Yuriko Schumacher, The Texas TribuneSchool vouchers, ofte ...

As described below, Cyprium is eligible to receive royalties and retains ownership of any Priority Review Voucher that may be issued. The CUTX-101 NDA submission is supported by positive topline ...

The education committees in both the House and Senate approved a $450 million bill, a top priority for Gov. Bill Lee. Legislators are expected to pass it quickly during a special session this week.

Gov. Bill Lee has called a special legislative session for Jan. 27 to deal with school vouchers, disaster relief and ...

Dordaviprone has received Rare Pediatric Disease Designation and has applied for a Rare Pediatric Disease Priority Review Voucher as part of the NDA process. About Chimerix Chimerix is ...